ArticleBreast cancer research and treatment2022

Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study.

Robert S Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.